Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Medistim ASA (MD1.F)

Compare
13.05
-0.60
(-4.40%)
At close: April 11 at 9:40:48 PM GMT+2
Loading Chart for MD1.F
  • Previous Close 13.65
  • Open 13.60
  • Bid --
  • Ask 13.50 x --
  • Day's Range 13.05 - 13.60
  • 52 Week Range 11.10 - 17.55
  • Volume 75
  • Avg. Volume 22
  • Market Cap (intraday) 240.693M
  • Beta (5Y Monthly) 1.06
  • PE Ratio (TTM) 27.77
  • EPS (TTM) 0.47
  • Earnings Date May 9, 2025
  • Forward Dividend & Yield 0.38 (2.95%)
  • Ex-Dividend Date Apr 25, 2024
  • 1y Target Est --

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

www.medistim.com

154

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MD1.F

View More

Performance Overview: MD1.F

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is OBX Total Return Index (OBX.OL) .

YTD Return

MD1.F
3.57%
OBX Total Return Index (OBX.OL)
0.56%

1-Year Return

MD1.F
13.56%
OBX Total Return Index (OBX.OL)
5.70%

3-Year Return

MD1.F
11.65%
OBX Total Return Index (OBX.OL)
16.78%

5-Year Return

MD1.F
131.71%
OBX Total Return Index (OBX.OL)
99.80%

Compare To: MD1.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MD1.F

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    240.69M

  • Enterprise Value

    227.99M

  • Trailing P/E

    27.94

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.16

  • Price/Book (mrq)

    6.63

  • Enterprise Value/Revenue

    4.92

  • Enterprise Value/EBITDA

    17.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    18.67%

  • Return on Assets (ttm)

    15.16%

  • Return on Equity (ttm)

    24.88%

  • Revenue (ttm)

    556.16M

  • Net Income Avi to Common (ttm)

    103.83M

  • Diluted EPS (ttm)

    0.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    179.21M

  • Total Debt/Equity (mrq)

    7.87%

  • Levered Free Cash Flow (ttm)

    81.67M

Research Analysis: MD1.F

View More

Company Insights: MD1.F

Research Reports: MD1.F

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.